BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 26899542)

  • 1. Telomerase activity in pancreatic juice differentiates pancreatic cancer from chronic pancreatitis: A meta-analysis.
    Hata T; Ishida M; Motoi F; Yamaguchi T; Naitoh T; Katayose Y; Egawa S; Unno M
    Pancreatology; 2016; 16(3):372-81. PubMed ID: 26899542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A highly sensitive and quantitative telomerase activity assay with pancreatic juice is useful for diagnosis of pancreatic carcinoma without problems due to polymerase chain reaction inhibitors: analysis of 100 samples of pancreatic juice from consecutive patients.
    Ohuchida K; Mizumoto K; Ishikawa N; Sato N; Nagai E; Yamaguchi K; Takaishi H; Ide T; Tanaka M
    Cancer; 2004 Nov; 101(10):2309-17. PubMed ID: 15476274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of human telomerase reverse transcriptase in pancreatic juice as a biomarker of pancreatic malignancy.
    Nakashima A; Murakami Y; Uemura K; Hayashidani Y; Sudo T; Hashimoto Y; Ohge H; Oda M; Sueda T; Hiyama E
    Pancreas; 2009 Jul; 38(5):527-33. PubMed ID: 19342980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In situ telomerase activity in pancreatic juice may discriminate pancreatic cancer from other pancreatic diseases.
    Uehara H; Nakaizumi A; Iishi H; Takenaka A; Eguchi H; Ohigashi H; Ishikawa O
    Pancreas; 2008 Apr; 36(3):236-40. PubMed ID: 18362835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telomerase activity in pancreatic juice differentiates ductal carcinoma from adenoma and pancreatitis.
    Suehara N; Mizumoto K; Tanaka M; Niiyama H; Yokohata K; Tominaga Y; Shimura H; Muta T; Hamasaki N
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2479-83. PubMed ID: 9815650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic Juice Exosomal MicroRNAs as Biomarkers for Detection of Pancreatic Ductal Adenocarcinoma.
    Nakamura S; Sadakari Y; Ohtsuka T; Okayama T; Nakashima Y; Gotoh Y; Saeki K; Mori Y; Nakata K; Miyasaka Y; Onishi H; Oda Y; Goggins M; Nakamura M
    Ann Surg Oncol; 2019 Jul; 26(7):2104-2111. PubMed ID: 30820789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic review and meta-analysis: Diagnostic performance of DNA alterations in pancreatic juice for the detection of pancreatic cancer.
    Visser IJ; Levink IJM; Peppelenbosch MP; Fuhler GM; Bruno MJ; Cahen DL
    Pancreatology; 2022 Nov; 22(7):973-986. PubMed ID: 35864067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of pancreatic cancer by detecting telomerase activity in pancreatic juice: comparison with K-ras mutations.
    Uehara H; Nakaizumi A; Tatsuta M; Baba M; Takenaka A; Uedo N; Sakai N; Yano H; Iishi H; Ohigashi H; Ishikawa O; Okada S; Kakizoe T
    Am J Gastroenterol; 1999 Sep; 94(9):2513-8. PubMed ID: 10484017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Specific activation of telomerase in pancreatic cancer tissue and preoperative diagnosis of pancreatic cancer by telomerase in pancreatic juice].
    Suehara N; Mizumoto K; Niiyama H; Tanaka M
    Nihon Rinsho; 1998 May; 56(5):1223-8. PubMed ID: 9613127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative assessment of the diagnostic role of human telomerase activity from pancreatic juice in pancreatic cancer.
    Wang S; Chen X; Tang M
    Tumour Biol; 2014 Aug; 35(8):7897-904. PubMed ID: 24828013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Effect of Driver Mutations of
    Gu Y; Ji Y; Jiang H; Qiu G
    Genet Test Mol Biomarkers; 2020 Dec; 24(12):777-788. PubMed ID: 33347393
    [No Abstract]   [Full Text] [Related]  

  • 12. Accurate discrimination of pancreatic ductal adenocarcinoma and chronic pancreatitis using multimarker expression data and samples obtained by minimally invasive fine needle aspiration.
    Chen Y; Zheng B; Robbins DH; Lewin DN; Mikhitarian K; Graham A; Rumpp L; Glenn T; Gillanders WE; Cole DJ; Lu X; Hoffman BJ; Mitas M
    Int J Cancer; 2007 Apr; 120(7):1511-7. PubMed ID: 17192896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of human telomerase reverse transcriptase (hTERT) expression in tissue and pancreatic juice from pancreatic cancer.
    Hashimoto Y; Murakami Y; Uemura K; Hayashidani Y; Sudo T; Ohge H; Fukuda E; Sueda T; Hiyama E
    Surgery; 2008 Jan; 143(1):113-25. PubMed ID: 18154939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum tumor markers and molecular biological diagnosis in pancreatic cancer.
    Sawabu N; Watanabe H; Yamaguchi Y; Ohtsubo K; Motoo Y
    Pancreas; 2004 Apr; 28(3):263-7. PubMed ID: 15084968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomerase activity as a marker for differential diagnosis of pancreatic adenocarcinoma: a systematic review and meta-analysis.
    Gu H; Xin X; Pan Y; Zhang H; Tian S; Sun C
    Int J Biol Markers; 2016 May; 31(2):e126-37. PubMed ID: 26616232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis.
    Mayerle J; Kalthoff H; Reszka R; Kamlage B; Peter E; Schniewind B; González Maldonado S; Pilarsky C; Heidecke CD; Schatz P; Distler M; Scheiber JA; Mahajan UM; Weiss FU; Grützmann R; Lerch MM
    Gut; 2018 Jan; 67(1):128-137. PubMed ID: 28108468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor marker M2-pyruvate-kinase in differential diagnosis of chronic pancreatitis and pancreatic cancer.
    Novotný I; Dítĕ P; Dastych M; Záková A; Trna J; Novotná H; Nechutová H
    Hepatogastroenterology; 2008; 55(85):1475-7. PubMed ID: 18795715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemically detected expression of 3 major genes (CDKN2A/p16, TP53, and SMAD4/DPC4) strongly predicts survival in patients with resectable pancreatic cancer.
    Oshima M; Okano K; Muraki S; Haba R; Maeba T; Suzuki Y; Yachida S
    Ann Surg; 2013 Aug; 258(2):336-46. PubMed ID: 23470568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinction of Invasive Carcinoma Derived From Intraductal Papillary Mucinous Neoplasms From Concomitant Ductal Adenocarcinoma of the Pancreas Using Molecular Biomarkers.
    Tamura K; Ohtsuka T; Date K; Fujimoto T; Matsunaga T; Kimura H; Watanabe Y; Miyazaki T; Ohuchida K; Takahata S; Ishigami K; Oda Y; Mizumoto K; Nakamura M; Tanaka M
    Pancreas; 2016 Jul; 45(6):826-35. PubMed ID: 26646266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of cathepsin E in pancreatic juice in the diagnosis of pancreatic ductal adenocarcinoma.
    Uno K; Azuma T; Nakajima M; Yasuda K; Hayakumo T; Mukai H; Sakai T; Kawai K
    J Gastroenterol Hepatol; 2000 Nov; 15(11):1333-8. PubMed ID: 11129230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.